IGAM
REGN icon

iA Global Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

iA Global Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16M Sell
20,646
-368
-2% -$282K 0.23% 96
2025
Q4 		$16.2M Buy
21,014
+766
+4% +$520K 0.21% 104
2025
Q3 		$11.4M Buy
20,248
+1,008
+5% +$570K 0.16% 115
2025
Q2 		$10.1M Buy
19,240
+6
+0% +$3.35K 0.15% 116
2025
Q1 		$12.2M Buy
19,234
+7,586
+65% +$5.22M 0.21% 89
2024
Q4 		$8.3M Sell
11,648
-1,538
-12% -$1.29M 0.15% 114
2024
Q3 		$13.9M Buy
13,186
+2,541
+24% +$2.83M 0.24% 78
2024
Q2 		$11.2M Sell
10,645
-2,177
-17% -$2.11M 0.21% 82
2024
Q1 		$12.3M Buy
12,822
+3,188
+33% +$3.03M 0.25% 81
2023
Q4 		$8.46M Buy
9,634
+737
+8% +$607K 0.2% 93
2023
Q3 		$7.32M Sell
8,897
-486
-5% -$382K 0.19% 101
2023
Q2 		$6.74M Buy
+9,383
New +$7.23M 0.18% 105

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

iA Global Asset Management's REGN Position: Q1 2026 in Review

iA Global Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.8% in Q1 2026, selling an estimated $282K and leaving 20,646 shares worth $16M. The position accounts for 0.23% of the portfolio, ranked #96.

iA Global Asset Management first reported a position in REGN in Q2 2023 and has held it in 12 quarters since. The position peaked at $16.2M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • iA Global Asset Management held 20,646 shares of Regeneron Pharmaceuticals worth $16M as of Q1 2026.
  • iA Global Asset Management sold 368 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $282K.
  • Regeneron Pharmaceuticals made up 0.23% of iA Global Asset Management's portfolio in Q1 2026, its #96 holding.
  • iA Global Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • iA Global Asset Management's Regeneron Pharmaceuticals position peaked at $16.2M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on iA Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.